Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With no annotations, the description carries the full burden. It does disclose one real behavioral trait, the paid/trial model ('5 free trial calls per signed wallet'), but says nothing about what happens when chain/token/address are omitted or invalid, whether all three are needed, error or rate-limit behavior, or what the response contains.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

One short sentence, front-loaded with the useful part, so there is no padding. The redundant 'x402-token-market:' prefix and the emoji/promo tail consume space without adding selection value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a three-parameter market-data tool with no annotations, no output schema, and 0% parameter documentation, the description is far too thin. An agent knows roughly what data it returns but not how to supply the inputs or what the result looks like.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 0% across three parameters (chain, token, address), and the description supplies no meaning for any of them. It never clarifies whether a chain name or chain ID is expected, whether token is a symbol or contract, or how address relates to token.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a specific data source and resource ('DexScreener token market') plus the metrics returned (price/liquidity/volume), which is more than a restatement of the name. It does not, however, distinguish this from the many overlapping siblings such as x402-dex-price, x402-token-price, x402-dex-scanner, or x402-token-liquidity-health, so an agent cannot tell which of these to pick.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

There is no when-to-use guidance, no exclusions, and no mention of alternatives despite a heavily overlapping sibling set. The only extra clause, '5 free trial calls per signed wallet', is billing context rather than selection guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.